People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Radius Health, Inc. | — | Pharmaceuticals | Series D+ | $191.2M | $4.5B | 2011 |
Martin K. Muenchbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Martin K. Muenchbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ansbert K Gadicke | 1 | 4 |
| Alan Nicholas Auerbach | 1 | 1 |
| Elizabeth K. Stoner | 1 | 1 |
| C. Richard Lyttle | 1 | 1 |
| Louis Nicholas O'Dea | 1 | 1 |
| Gary Nicholas Hattersley | 1 | 1 |
| Kurt K. Graves | 1 | 1 |
| Jonathan Nicholas Fleming | 1 | 1 |
| B. Nicholas Harvey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.